Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov-Dec;13(6):671-681.
doi: 10.1016/j.jobcr.2023.08.007. Epub 2023 Sep 6.

Comparing efficacies of autologous platelet concentrate preparations as mono-therapeutic agents in intra-bony defects through systematic review and meta-analysis

Shailesh Varshney  1 , Anshuman Dwivedi  2 , Vibha Dwivedi  3
Affiliations
Review

Comparing efficacies of autologous platelet concentrate preparations as mono-therapeutic agents in intra-bony defects through systematic review and meta-analysis

Shailesh Varshney et al. J Oral Biol Craniofac Res. 2023 Nov-Dec.

Abstract

Aim: This systematic review and meta-analysis aimed to assess individually the regenerative potential of PRF (Platelet-rich Fibrin), PRP (Platelet-rich Plasma), and PRGF (Plasma Rich in Growth Factors) in comparison to OFD (Open Flap Debridement) alone for treating Intrabony defects, by calculating pooled effect sizes.

Background: Relevant randomized controlled trials on humans were searched in PUBMED, COCHRANE CENTRAL, and GOOGLE SCHOLAR. Mean differences (MD) of Clinical Attachment level (CAL), Probing Pocket depth (PPD), and Defect Depth Reduction (DDR) between the Experimental and Control groups were used for calculating pooled effect sizes. Risk of bias was assessed using Cochrane's tool, and publication bias was evaluated through Funnel plots, Trim & Fill Method, and Rosenthal's Fail-Safe N Test.

Review result: A total of 23 studies were identified for qualitative and quantitative analysis. These studies were categorized into PRF, PRP, and PRGF groups based on the type of APC used. PRF showed the highest CAL gain (1.60 mm, 95% CI = 0.963-2.232 mm, P < 0.001, I2 = 93.83%) and PPD reduction (1.76 mm, 95% CI = 1.056 to 2.446, P < 0.001, I2 = 96.05%). However, PRP exhibited the greatest DDR (3.42 mm, 95% CI = -13.67 to -20.50, P = 0.011, I2 = 87.27%). PRF and PRP demonstrated large effect sizes, while PRGF showed a small effect size.

Conclusion: The use of PRF, PRP, and PRGF showed advantages in treating intrabony defects. However, caution is advised when interpreting the results due to heterogeneity and publication bias among the studies.

Keywords: Autologous platelet concentrates; Intra-bony defects; Plasma rich in growth factors; Platelet rich fibrin; Platelet rich plasma; Publication bias.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
PRISMA flow chart.
Fig. 2
Fig. 2
Forest plot and Funnel plot comparing OFD V/S OFD + PRF outcomes for CAL analysis.
Fig. 3
Fig. 3
Forest plot and Funnel plot comparing OFD V/S OFD + PRF outcomes for PPD analysis.
Fig. 4
Fig. 4
Forest plot and Funnel plot comparing OFD and OFD + PRF outcomes for DDR analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kirkwood K.L., Cirelli J.A., Rogers J.E., Giannobile W.V. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol. 2007;43:294–315. 2000. - PMC - PubMed
    1. Murphy K.G., Gunsolley J.C. Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review. Ann Periodontol. 2003;8:266–302. - PubMed
    1. Padial-Molina M., Marchesan J.T., Taut A.D., Jin Q., Giannobile W.V., Rios H.F. Methods to validate tooth supporting regenerative therapies. Methods Mol Biol. 2012;887:135–148. - PMC - PubMed
    1. Kiritsy C.P., Lynch A.B., Lynch S.E. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med. 1993;4:729–760. - PubMed
    1. Dohan Ehrenfest D.M., Andia 1, Zumstein M.A., Zhang C.Q., Pinto N.R., Bielecki T. Classification of platelet concentrates (platelet-rich plasma-PRP, platelet-rich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014;4:3–9. - PMC - PubMed